Related Experiment Video
Updated: Jun 1, 2026
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
Total synthesis of bryostatin 9
Paul A Wender1, Adam J Schrier
1Department of Chemistry, Stanford University, Stanford, California 94305-5080, USA. wenderp@stanford.edu
Journal of the American Chemical Society
|May 31, 2011
Summary
The total synthesis of bryostatin 9 was achieved through a novel, step-economical Prins-driven macrocyclization. This represents the most concise and convergent synthesis to date for this potent bryostatin.
Area of Science:
- Organic Chemistry
- Synthetic Chemistry
- Medicinal Chemistry
Background:
- Bryostatins are a class of marine natural products with significant therapeutic potential, particularly in cancer treatment.
- Developing efficient synthetic routes to bryostatins is crucial for further biological evaluation and drug development.
Purpose of the Study:
- To achieve the total synthesis of bryostatin 9.
- To develop a novel, step-economical, and convergent synthetic strategy for bryostatin 9.
Main Methods:
- A Prins-driven macrocyclization strategy was employed.
- The synthesis was designed to be highly convergent and step-economical.
Main Results:
- The total synthesis of bryostatin 9 was successfully accomplished.
- The synthesis required 25 linear and 42 total steps.
- This represents the most concise and convergent synthesis of a potent bryostatin reported to date.
Conclusions:
- The developed Prins-driven macrocyclization strategy is effective for the concise synthesis of bryostatin 9.
- This efficient synthesis paves the way for further exploration of bryostatin 9's biological activities and therapeutic applications.
